ScopusElsevier Scopus
Status
Inactive/Discontinued
Coverage
2008–2017
Source type
Journal
Open access
No
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Recent Patents on Endocrine, Metabolic and Immune Drug Discovery
Recent Patents on Endocrine, Metabolic and Immune Drug Discovery is not currently indexed in Scopus. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 1872-2148Verify ISSN ↗2212-3334Verify ISSN ↗
Publisher: Bentham Science Publishers
Scopus · Inactive
0
Indexed in
Cost to publish: No APC data — check the publisher
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Recent Patents on Endocrine, Metabolic and Immune Drug Discovery indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2008–2017).
What is the impact factor of Recent Patents on Endocrine, Metabolic and Immune Drug Discovery?
Recent Patents on Endocrine, Metabolic and Immune Drug Discovery has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Who publishes Recent Patents on Endocrine, Metabolic and Immune Drug Discovery and what is its ISSN?
Recent Patents on Endocrine, Metabolic and Immune Drug Discovery is published by Bentham Science Publishers. Its print ISSN is 1872-2148 and its online ISSN is 2212-3334.
Is Recent Patents on Endocrine, Metabolic and Immune Drug Discovery in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Recent Patents on Endocrine, Metabolic and Immune Drug Discovery open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Recent Patents on Endocrine, Metabolic and Immune Drug Discovery for 10 years, between 2008 and 2017. Coverage ended in 2017, 9 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 298 works and 3,974 citations for the title. Its papers appear as late as 2019, 2 years after Scopus coverage ended in 2017. That pattern fits a journal Scopus stopped indexing while it kept publishing, but it can also come from a changed ISSN or merged records. Confirm the journal's current status before submitting.
How well cited is Recent Patents on Endocrine, Metabolic and Immune Drug Discovery? — open metrics via OpenAlex
Recent Patents on Endocrine, Metabolic and Immune Drug Discovery has an h-index of 34 and a 2-year mean of 0 citations per paper (OpenAlex).
34
h-index
0
2-yr mean citations
104
i10-index
298
works indexed
3,974
total citations
Recent Patents on Endocrine, Metabolic and Immune Drug Discovery published 1 papers in 2019; its busiest recent year was 2012 with 51. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Recent Patents on Endocrine, Metabolic and Immune Drug Discovery? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2017. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2017
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Bentham Science Publishers
Bentham Science Publishers has 239 other titles in our data; 119 are currently indexed in Scopus.
Journal Scopus status
Adolescent Psychiatry Active Anti-Cancer Agents in Medicinal Chemistry Active Anti-Infective Agents Active Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry Active Cardiovascular and Hematological Disorders - Drug Targets Active Central Nervous System Agents in Medicinal Chemistry Active Related journals
8 journals Journal Indexed in
Recent Patents on Engineering Scopus Q3 Recent Patents on Food, Nutrition and Agriculture Not in these indexes Recent Patents on Inflammation and Allergy Drug Discovery Not in these indexes Recent Patents on Materials Science Not in these indexes Recent Patents on Mechanical Engineering Scopus Q3 Recent Patents on Medical Imaging Not in these indexes Recent Patents on Nanotechnology Scopus Q1 WoS SCIE Reviews on Recent Clinical Trials Scopus Q2 WoS ESCI
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.